Latest Patents News

Bayan Mining has locked in an exclusive worldwide licence for advanced rare earth processing technologies developed at Colorado School of Mines, promising higher recovery rates and lower costs for its Desert Star Project near Mountain Pass.

Memphasys Limited has restructured its leadership by eliminating the CEO role to back a direct-selling global commercialisation strategy for its Felix™ System, anticipating imminent CE Mark approval to enter the European IVF market.

4DMedical secures a key clinical adoption milestone as the University of Miami begins using its CT – VQ™ respiratory imaging technology, following Stanford’s lead. Meanwhile, Lahey Hospital inks a two-year deal for IQ-UIP™, underscoring growing traction in US academic medical centers.

Trigg Minerals has received tentative approval to begin diamond core drilling at its Antimony Canyon Project in Utah, focusing on high-grade stibnite mineralisation on private patented claims. Drilling is set to start before the end of December 2025, marking a key step from exploration to development.

ChemX Materials Limited has emerged from voluntary administration following a Deed of Company Arrangement, while securing a significant Japanese patent for its HiPurA® High Purity Alumina process.

Summit Minerals has agreed to acquire the historic Keystone Mine in Nevada, a polymetallic project boasting impressive historic grades of silver, gold, and tungsten. The acquisition positions Summit to tap into a prolific US mining district with significant critical metals potential.

Sparc Hydrogen has appointed Alana Barlow as its inaugural CEO, marking a strategic move to accelerate commercialisation of its innovative photocatalytic water splitting technology for green hydrogen.

Mandrake Resources has inked a binding agreement with DISA Technologies to recover uranium and critical minerals from abandoned mine waste across its expansive Utah Project, tapping into a growing US government-backed market.

Livium Ltd has secured a A$663,000 R&D tax rebate for its subsidiary VSPC, pushing total FY25 rebates to A$1.4 million and reinforcing its push into advanced battery materials and recycling.

Island Pharmaceuticals has been granted a pivotal US patent extending protection for its antiviral drug Galidesivir as a Covid-19 treatment until 2042, reinforcing its strategic position in the antiviral market.

Sparc Hydrogen has reached a pivotal milestone with sustained hydrogen generation at its Roseworthy pilot plant, advancing its innovative photocatalytic water splitting technology towards commercialisation.

Identitii Limited has announced a pro rata non-renounceable rights issue to raise approximately $2.88 million, partially underwritten by Beauvais Capital Pty Ltd. The funds will support the development and commercialisation of its BNDRY platform amid ongoing patent litigation risks.